Advertisement

Index by author

January 01, 2004; Volume 32,Issue 1

A

  1. Akasawa, Akira

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  2. Akimoto, Masayuki

    1. CATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATION
      Izumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan Chiba
      Drug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7

  3. Alipour, Masumeh

    1. CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR
      Sarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. Kocarek
      Drug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66

  4. Ang, Catharina Y.W.

    1. IN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMS
      Yanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian Leakey
      Drug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28

  5. Arai, Masayuki

    1. CATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATION
      Izumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan Chiba
      Drug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7

B

  1. Basly, Jean-Philippe

    1. METABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVER
      Angéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline Teyssier
      Drug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58

  2. Beger, Richard D.

    1. IN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMS
      Yanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian Leakey
      Drug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28

  3. Blanchard, Andrew P.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  4. Brocks, D.R.

    1. SUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATS
      J. Kalitsky-Szirtes, A. Shayeganpour, D.R. Brocks and M. Piquette-Miller
      Drug Metabolism and Disposition January 2004, 32 (1) 20-27; DOI: https://doi.org/10.1124/dmd.32.1.20

  5. Broudy, Marc I.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  6. Brunengraber, Henri

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  7. Brunengraber, Laura L.

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

C

  1. Canivenc-Lavier, Marie-Chantal

    1. METABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVER
      Angéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline Teyssier
      Drug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58

  2. Cargill, Catherine E.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  3. Chen, Cuiping

    1. DEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITY
      Xingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. Smith
      Drug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132

  4. Chiba, Kan

    1. CATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATION
      Izumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan Chiba
      Drug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7

  5. Comte, Blandine

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  6. Crespi, Charles L.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  7. Crews, Brenda C.

    1. STUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITES
      Rory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. Marnett
      Drug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113

  8. Cui, Yanyan

    1. IN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMS
      Yanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian Leakey
      Drug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28

D

  1. Dahms, William

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  2. Dalvie, Deepak K.

    1. CHARACTERIZATION OF NOVEL DIHYDROTHIENOPYRIDINIUM AND THIENOPYRIDINIUM METABOLITES OF TICLOPIDINE IN VITRO: ROLE OF PEROXIDASES, CYTOCHROMES P450, AND MONOAMINE OXIDASES
      Deepak K. Dalvie and Thomas N. O'Connell
      Drug Metabolism and Disposition January 2004, 32 (1) 49-57; DOI: https://doi.org/10.1124/dmd.32.1.49

  3. Dandeneau, Andre A.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  4. David, France

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  5. Dehal, Shangara S.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  6. DeMarini, David M.

    1. METABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANE
      Rogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. Evans
      Drug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123

  7. Doerge, Daniel R.

    1. CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4
      Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip Lazarus
      Drug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72

  8. Doss, George A.

    1. N-ACETYLATION OF THE GLUTAMATE RESIDUE OF INTACT GLUTATHIONE CONJUGATES IN RATS: A NOVEL PATHWAY FOR THE METABOLIC PROCESSING OF THIOL ADDUCTS OF XENOBIOTICS
      Wenji Yin, George A. Doss, Ralph A. Stearns and Sanjeev Kumar
      Drug Metabolism and Disposition January 2004, 32 (1) 43-48; DOI: https://doi.org/10.1124/dmd.32.1.43

E

  1. Eckett, Nina

    1. THE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURE
      Lydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick Maurel
      Drug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80

  2. Eckstein, James A.

    1. AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES
      Matthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. Wrighton
      Drug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140

  3. Erve, John C. L.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  4. Evans, Marina V.

    1. METABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANE
      Rogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. Evans
      Drug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123

F

  1. Fabre, Jean-Michel

    1. THE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURE
      Lydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick Maurel
      Drug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80

  2. Fang, Jia-Long

    1. CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4
      Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip Lazarus
      Drug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72

G

  1. Gargano, Mary D.

    1. CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR
      Sarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. Kocarek
      Drug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66

  2. Goodwin, Joseph J.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  3. Gradolatto, Angéline

    1. METABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVER
      Angéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline Teyssier
      Drug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58

  4. Granville, Courtney

    1. METABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANE
      Rogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. Evans
      Drug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123

H

  1. Halpert, James R.

    1. TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS
      Yoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. Halpert
      Drug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155

  2. Hasegawa, Ryuichi

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  3. He, You Ai

    1. TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS
      Yoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. Halpert
      Drug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155

  4. He, You Qun

    1. TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS
      Yoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. Halpert
      Drug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155

  5. Hebbel, Robert P.

    1. METABOLISM OF OPIOIDS IS ALTERED IN LIVER MICROSOMES OF SICKLE CELL TRANSGENIC MICE
      Swati Nagar, Rory P. Remmel, Robert P. Hebbel and Cheryl L. Zimmerman
      Drug Metabolism and Disposition January 2004, 32 (1) 98-104; DOI: https://doi.org/10.1124/dmd.32.1.98

  6. Heinze, Thomas M.

    1. IN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMS
      Yanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian Leakey
      Drug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28

  7. Higuchi, Shohei

    1. CATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATION
      Izumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan Chiba
      Drug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7

  8. Hirota, Mitsuyo

    1. CATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATION
      Izumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan Chiba
      Drug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7

  9. Ho, Thuy

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  10. Hu, Lihong

    1. IN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMS
      Yanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian Leakey
      Drug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28

I

  1. Iida, Izumi

    1. CATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATION
      Izumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan Chiba
      Drug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7

J

  1. Jobbins, Kathryn

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  2. Jones, Jeffrey P.

    1. METABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANE
      Rogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. Evans
      Drug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123

K

  1. Kalgutkar, Amit S.

    1. STUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITES
      Rory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. Marnett
      Drug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113

  2. Kalitsky-Szirtes, J.

    1. SUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATS
      J. Kalitsky-Szirtes, A. Shayeganpour, D.R. Brocks and M. Piquette-Miller
      Drug Metabolism and Disposition January 2004, 32 (1) 20-27; DOI: https://doi.org/10.1124/dmd.32.1.20

  3. Kamakura, Shiro

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  4. Kasper, Steve C.

    1. AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES
      Matthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. Wrighton
      Drug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140

  5. Kasumov, Takhar

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  6. Kelly, Rebecca S.

    1. DEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITY
      Xingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. Smith
      Drug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132

  7. Kerr, Douglas

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  8. Khan, Kishore K.

    1. TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS
      Yoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. Halpert
      Drug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155

  9. Kinman, Renee

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  10. Kitakaze, Masafumi

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  11. Kobayashi, Kaoru

    1. CATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATION
      Izumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan Chiba
      Drug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7

  12. Kocarek, Thomas A.

    1. CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR
      Sarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. Kocarek
      Drug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66

  13. Komamura, Kazuo

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  14. Koyano, Satoru

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  15. Kozak, Kevin R.

    1. STUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITES
      Rory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. Marnett
      Drug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113

  16. Kumar, Sanjeev

    1. N-ACETYLATION OF THE GLUTAMATE RESIDUE OF INTACT GLUTATHIONE CONJUGATES IN RATS: A NOVEL PATHWAY FOR THE METABOLIC PROCESSING OF THIOL ADDUCTS OF XENOBIOTICS
      Wenji Yin, George A. Doss, Ralph A. Stearns and Sanjeev Kumar
      Drug Metabolism and Disposition January 2004, 32 (1) 43-48; DOI: https://doi.org/10.1124/dmd.32.1.43

  17. Kurose, Kouichi

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

L

  1. Laskey, John

    1. METABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANE
      Rogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. Evans
      Drug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123

  2. Lazarus, Philip

    1. CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4
      Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip Lazarus
      Drug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72

  3. Leakey, Julian

    1. IN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMS
      Yanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian Leakey
      Drug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28

  4. Li, Yuxin

    1. THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES
      Xiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang Yan
      Drug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35

  5. Liu, Xingrong

    1. DEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITY
      Xingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. Smith
      Drug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132

  6. Lucas, Catherine

    1. THE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURE
      Lydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick Maurel
      Drug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80

M

  1. Marnett, Lawrence J.

    1. STUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITES
      Rory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. Marnett
      Drug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113

  2. Matsumoto, Kenji

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  3. Maurel, Patrick

    1. THE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURE
      Lydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick Maurel
      Drug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80

  4. Mercer-Haines, Nancy A.

    1. CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR
      Sarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. Kocarek
      Drug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66

  5. Miyata, Atsunori

    1. CATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATION
      Izumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan Chiba
      Drug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7

N

  1. Nagar, Swati

    1. METABOLISM OF OPIOIDS IS ALTERED IN LIVER MICROSOMES OF SICKLE CELL TRANSGENIC MICE
      Swati Nagar, Rory P. Remmel, Robert P. Hebbel and Cheryl L. Zimmerman
      Drug Metabolism and Disposition January 2004, 32 (1) 98-104; DOI: https://doi.org/10.1124/dmd.32.1.98

  2. Nakajima, Toshiharu

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  3. Nissim, Itzhak

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

O

  1. O'Connell, Thomas N.

    1. CHARACTERIZATION OF NOVEL DIHYDROTHIENOPYRIDINIUM AND THIENOPYRIDINIUM METABOLITES OF TICLOPIDINE IN VITRO: ROLE OF PEROXIDASES, CYTOCHROMES P450, AND MONOAMINE OXIDASES
      Deepak K. Dalvie and Thomas N. O'Connell
      Drug Metabolism and Disposition January 2004, 32 (1) 49-57; DOI: https://doi.org/10.1124/dmd.32.1.49

  2. Obach, R. Scott

    1. POTENT INHIBITION OF HUMAN LIVER ALDEHYDE OXIDASE BY RALOXIFENE
      R. Scott Obach
      Drug Metabolism and Disposition January 2004, 32 (1) 89-97; DOI: https://doi.org/10.1124/dmd.32.1.89

  3. Ozawa, Shogo

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

P

  1. Patten, Christopher J.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  2. Petullo, David M.

    1. AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES
      Matthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. Wrighton
      Drug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140

  3. Pichard-Garcia, Lydiane

    1. THE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURE
      Lydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick Maurel
      Drug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80

  4. Piquette-Miller, M.

    1. SUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATS
      J. Kalitsky-Szirtes, A. Shayeganpour, D.R. Brocks and M. Piquette-Miller
      Drug Metabolism and Disposition January 2004, 32 (1) 20-27; DOI: https://doi.org/10.1124/dmd.32.1.20

  5. Porter, Todd D.

    1. JUD COON: 35 YEARS OF P450 RESEARCH, A SYNOPSIS OF P450 HISTORY
      Todd D. Porter
      Drug Metabolism and Disposition January 2004, 32 (1) 1-6; DOI: https://doi.org/10.1124/dmd.32.1.1

  6. Puchowicz, Michelle A.

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

R

  1. Remmel, Rory P.

    1. STUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITES
      Rory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. Marnett
      Drug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113
    2. METABOLISM OF OPIOIDS IS ALTERED IN LIVER MICROSOMES OF SICKLE CELL TRANSGENIC MICE
      Swati Nagar, Rory P. Remmel, Robert P. Hebbel and Cheryl L. Zimmerman
      Drug Metabolism and Disposition January 2004, 32 (1) 98-104; DOI: https://doi.org/10.1124/dmd.32.1.98

  2. Ross, Matthew K.

    1. METABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANE
      Rogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. Evans
      Drug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123

  3. Runge-Morris, Melissa

    1. CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR
      Sarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. Kocarek
      Drug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66

S

  1. Sachdeva, Karuna

    1. THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES
      Xiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang Yan
      Drug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35

  2. Saito, Hirohisa

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  3. Saito, Yoshiro

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  4. Sawada, Jun-Ichi

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  5. Scarfe, Graeme

    1. THE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURE
      Lydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick Maurel
      Drug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80

  6. Sharma, Raman

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

  7. Shayeganpour, A.

    1. SUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATS
      J. Kalitsky-Szirtes, A. Shayeganpour, D.R. Brocks and M. Piquette-Miller
      Drug Metabolism and Disposition January 2004, 32 (1) 20-27; DOI: https://doi.org/10.1124/dmd.32.1.20

  8. Shenoy, Sarita D.

    1. CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR
      Sarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. Kocarek
      Drug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66

  9. Siess, Marie-Hélène

    1. METABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVER
      Angéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline Teyssier
      Drug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58

  10. Smith, Bill J.

    1. DEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITY
      Xingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. Smith
      Drug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132

  11. Soars, Matthew G.

    1. AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES
      Matthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. Wrighton
      Drug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140

  12. Song, Xiulong

    1. THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES
      Xiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang Yan
      Drug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35

  13. Spencer, Thomas A.

    1. CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR
      Sarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. Kocarek
      Drug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66

  14. Stearns, Ralph A.

    1. N-ACETYLATION OF THE GLUTAMATE RESIDUE OF INTACT GLUTATHIONE CONJUGATES IN RATS: A NOVEL PATHWAY FOR THE METABOLIC PROCESSING OF THIOL ADDUCTS OF XENOBIOTICS
      Wenji Yin, George A. Doss, Ralph A. Stearns and Sanjeev Kumar
      Drug Metabolism and Disposition January 2004, 32 (1) 43-48; DOI: https://doi.org/10.1124/dmd.32.1.43

  15. Stresser, David M.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

T

  1. Teyssier, Caroline

    1. METABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVER
      Angéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline Teyssier
      Drug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58

  2. Thomas, Katherine

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  3. Tornero-Velez, Rogelio

    1. METABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANE
      Rogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. Evans
      Drug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123

  4. Tu, Meihua

    1. DEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITY
      Xingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. Smith
      Drug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132

  5. Turner, Stephanie D.

    1. HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE
      David M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. Crespi
      Drug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105

U

  1. Ueno, Kazuyuki

    1. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION
      Satoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi Sawada
      Drug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149

  2. Upadhyaya, Pramod

    1. CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4
      Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip Lazarus
      Drug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72

W

  1. Weaver, Richard John

    1. THE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURE
      Lydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick Maurel
      Drug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80

  2. Wehrli, Suzanne

    1. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS
      Takhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri Brunengraber
      Drug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10

  3. Wiener, Doris

    1. CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4
      Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip Lazarus
      Drug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72

  4. Wrighton, Steven A.

    1. AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES
      Matthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. Wrighton
      Drug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140

X

  1. Xie, Mingxing

    1. THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES
      Xiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang Yan
      Drug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35

Y

  1. Yamaguchi, Yoshitaka

    1. TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS
      Yoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. Halpert
      Drug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155

  2. Yan, Bingfang

    1. THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES
      Xiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang Yan
      Drug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35

  3. Yin, Wenji

    1. N-ACETYLATION OF THE GLUTAMATE RESIDUE OF INTACT GLUTATHIONE CONJUGATES IN RATS: A NOVEL PATHWAY FOR THE METABOLIC PROCESSING OF THIOL ADDUCTS OF XENOBIOTICS
      Wenji Yin, George A. Doss, Ralph A. Stearns and Sanjeev Kumar
      Drug Metabolism and Disposition January 2004, 32 (1) 43-48; DOI: https://doi.org/10.1124/dmd.32.1.43

Z

  1. Zhang, He

    1. THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES
      Xiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang Yan
      Drug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35

  2. Zimmerman, Cheryl L.

    1. METABOLISM OF OPIOIDS IS ALTERED IN LIVER MICROSOMES OF SICKLE CELL TRANSGENIC MICE
      Swati Nagar, Rory P. Remmel, Robert P. Hebbel and Cheryl L. Zimmerman
      Drug Metabolism and Disposition January 2004, 32 (1) 98-104; DOI: https://doi.org/10.1124/dmd.32.1.98
Back to top

In this issue